Hemab Therapeutics Holdings, Inc. Common Stock
$34.74
▼ 0.98
(-2.74%)
Volume: 266,532
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -29.4%
- MA aligned bearish
- RSI 28 oversold
🎯
Pullback
69
- RSI 28 near lows
- Near lower Bollinger band
- -15.7% vs 20MA
💎
Value
58
- -37% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)27.7
MACD-0.667
MA trendBearish
ATR9.45%
21d mom.-29.4%
63d mom.+7.3%
vs 20MA-15.7%
RVOL(20)0.45×
52w low · 23
52w high · 55
-37.3% from 52-week high
20d support 34
· resistance 49
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap—
PER—
PBR—
PSR—
EPS—
ROE—
ROA—
Dividend yield—
Debt/Equity—
EV/EBITDA—
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -15.66% | -29.38% | +7.32% | — | — | +2.18% |
Valuation and profitability in USD. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -21.77%, daily vol 3.66%. Hemab Therapeutics Holdings, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.